X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8954) 8954
Publication (1038) 1038
Book Review (75) 75
Book Chapter (52) 52
Newsletter (29) 29
Book / eBook (12) 12
Conference Proceeding (12) 12
Dissertation (4) 4
Magazine Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5696) 5696
animals (3042) 3042
index medicus (2950) 2950
topoisomerase ii inhibitors (2360) 2360
pharmacology & pharmacy (2105) 2105
antineoplastic agents - pharmacology (2074) 2074
oncology (1918) 1918
topoisomerase i inhibitors (1764) 1764
enzyme inhibitors - pharmacology (1746) 1746
biochemistry & molecular biology (1693) 1693
chemistry, medicinal (1585) 1585
cell line, tumor (1433) 1433
camptothecin - pharmacology (1382) 1382
mice (1351) 1351
cancer (1293) 1293
apoptosis (1241) 1241
dna topoisomerases, type ii - metabolism (1221) 1221
structure-activity relationship (1095) 1095
dna damage (1082) 1082
dna topoisomerases, type i - metabolism (1079) 1079
female (1055) 1055
dna (1036) 1036
camptothecin (1034) 1034
apoptosis - drug effects (971) 971
tumor cells, cultured (951) 951
dose-response relationship, drug (886) 886
etoposide - pharmacology (861) 861
camptothecin - analogs & derivatives (853) 853
antineoplastic agents - chemistry (813) 813
male (780) 780
cytotoxicity (741) 741
dna - metabolism (729) 729
topoisomerase-ii (721) 721
molecular structure (720) 720
antineoplastic agents, phytogenic - pharmacology (699) 699
drug screening assays, antitumor (687) 687
cell biology (675) 675
chemotherapy (675) 675
inhibitors (657) 657
cell survival - drug effects (647) 647
cell proliferation - drug effects (639) 639
antineoplastic agents - chemical synthesis (627) 627
mechanism (611) 611
anti-bacterial agents - pharmacology (605) 605
topoisomerase-i (602) 602
derivatives (600) 600
cell line (597) 597
topoisomerase ii inhibitors - pharmacology (594) 594
etoposide (588) 588
research (562) 562
drug resistance (543) 543
analysis (542) 542
mutation (538) 538
microbiology (536) 536
dna topoisomerase (534) 534
expression (528) 528
cells (526) 526
neoplasms - drug therapy (518) 518
inhibition (504) 504
topoisomerase i inhibitors - pharmacology (503) 503
drugs (502) 502
cell cycle - drug effects (499) 499
chemistry, organic (497) 497
microbial sensitivity tests (488) 488
models, molecular (473) 473
research article (459) 459
resistance (452) 452
binding (448) 448
article (446) 446
in-vitro (429) 429
topotecan (423) 423
phosphorylation (421) 421
proteins (419) 419
cell cycle (414) 414
enzymes (414) 414
topoisomerase (404) 404
dna topoisomerases, type ii - genetics (402) 402
drug design (400) 400
topoisomerase ii (397) 397
enzyme inhibitors - chemistry (392) 392
deoxyribonucleic acid--dna (390) 390
escherichia-coli (385) 385
antineoplastic agents - therapeutic use (384) 384
drug resistance, neoplasm (378) 378
dna-binding proteins - metabolism (376) 376
dna gyrase (375) 375
dna repair (375) 375
agents (369) 369
kinetics (366) 366
doxorubicin - pharmacology (361) 361
rats (361) 361
antitumor-activity (355) 355
cell division - drug effects (354) 354
molecular sequence data (351) 351
dna topoisomerases (346) 346
dna topoisomerase-ii (345) 345
irinotecan (343) 343
base sequence (336) 336
cleavage (336) 336
topoisomerase i (334) 334
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8846) 8846
Japanese (48) 48
German (31) 31
Russian (31) 31
French (26) 26
Chinese (14) 14
Spanish (11) 11
Italian (5) 5
Portuguese (4) 4
Polish (2) 2
Slovenian (2) 2
Turkish (2) 2
Czech (1) 1
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Nature, ISSN 0028-0836, 04/2015, Volume 520, Issue 7546, pp. 239 - 242
Non-small-cell lung cancer is the leading cause of cancer-related death worldwide(1). Chemotherapies such as the topoisomerase II (TopoII) inhibitor etoposide... 
ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | COMPLEXES | SWI/SNF | GROWTH | GENE-EXPRESSION | ANTAGONISM | MUTATIONS | CANCER | POLYCOMB | MICROARRAY DATA | Polycomb Repressive Complex 2 - antagonists & inhibitors | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Humans | Lung Neoplasms - pathology | Molecular Targeted Therapy | Antineoplastic Agents, Phytogenic - therapeutic use | Nuclear Proteins - genetics | DNA Helicases - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Genes, erbB-1 - genetics | Etoposide - pharmacology | Etoposide - therapeutic use | Topoisomerase II Inhibitors - pharmacology | Transcription Factors - genetics | Anaphase - drug effects | Enhancer of Zeste Homolog 2 Protein | Topoisomerase II Inhibitors - therapeutic use | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Protein research | Care and treatment | Oncology, Experimental | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Gene expression | Cancer | Proteins | Genes | Lung cancer | Genetic engineering | Mutation | Kinases | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Apoptosis | Etoposide | Chemotherapy | EZH2 inhibition | BRG1 | EGFR
Journal Article
Nature, ISSN 0028-0836, 01/2012, Volume 481, Issue 7380, pp. 185 - 191
Journal Article
Journal Article
Journal Article